US pharmaceutical firms’ international redeployment strategies, entry modes, and performance outcomes

This dissertation provides three empirical studies investigating multinational enterprises’ (MNEs) entry mode decisions, performance outcomes of the sequential moves of divestitures and subsequent greenfield investments, and expatriate staffing, respectively. From the redeployability perspective, all three empirical studies explore how MNEs’ sequential decision-making may help modify their resource base to improve performance and secure competitive advantage. With the context of US pharmaceutical firms’ global investments, this dissertation seeks to connect the redeployability perspective with international business (IB) phenomena and thus provide more empirical evidence for this value-creation mechanism through which firms free up and redeploy resources across countries. In addition, this dissertation examines potential boundary conditions for the redeployability perspective in IB research.

Name thesis:degree_name

Ph.D.

Level thesis:degree_level

Dissertation

Discipline thesis:degree_discipline

Business Administration

Grantor

University of Illinois at Urbana-Champaign

Year dc:date

2023

Author dc:creator

• Xu, Mingrui

Contributors dc:contributor

• Mahoney, Joseph T.
• Yao, Fiona Kun
• Sakhartov, Arkadiy
• Schijven, Mario

• Redeployability
• Resource Redeployment
• Entry Mode
• Expatriate Staffing
• Pharmaceutical Industry

Statement dc:rights

• Copyright 2023 Mingrui Xu

Language dc:language

en, eng

Handle dc:identifier

https://hdl.handle.net/2142/121323

OAI record oai:identifier

https://www.ideals.illinois.edu/oai-pmh?verb=GetRecord&metadataPrefix=etdms&identifier=oai%3Awww.ideals.illinois.edu%3A2142%2F121323